A Study of ResCure™ to Treat COVID-19 Infection

Withdrawn before enrolling · Phase 1

Conditions studied: COVID, Covid-19, Corona Virus Infection, Sars-CoV2, Coronavirus-19, SARS Pneumonia, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

In brief

This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.

Key facts

Study ID

NCT04395716

Run by

ProgenaBiome

People needed

0

Starts

2020-01-01

Expected to finish

2021-11-01

Last updated by the study team

2021-04-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Critically ill patients with SARS from COVID-19 infection on respirators OR
• Patients with SARS from COVID-19 infection prior or after being placed on respirator
• Male or female patients 18 years of age and older

You may not qualify if…

• Patients less than 18 years of age

Where it is running

• ProgenaBiome — Ventura, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.